11 February 2021 : Clinical Research
Effect of ¹³¹I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer
Zhongying Rui1CDEF, Ruixin Wu1BCD, Wei Zheng1ADG*, Xuan Wang1BDF, Zhaowei Meng1AF, Jian Tan1AFDOI: 10.12659/MSM.929590
Med Sci Monit 2021; 27:e929590
Figure 1 Changes in lymphocyte counts after 131I treatment cycles. The counts consistently declined from the first to the third 131I cycles and then increased after the fourth 131I therapy. The decrease that was statistically significant compared with the baseline lymphocyte count occurred after the third 131I cycle (1.44±0.43 vs 1.90±0.63, P=0.001).